Jasper Therapeutics (JSPR) PT Lowered to $6 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Price: $0.79 --0%
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Cantor Fitzgerald analyst Pete Stavropoulos lowered the price target on Jasper Therapeutics (NASDAQ: JSPR) to $6.00 (from $10.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Ur-Energy (URE:CN) (URG) PT Lowered to Cdn$1.60 at RBC Capital
- Deutsche Bank Downgrades SentinelOne Inc (S) to Hold on Valuation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
